- Nachrichtendetail
-
27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
LIGAND PHARMAC.NEW DL-001 | A1C9RN | Frankfurt | 98,500 | 29.07.24 15:57:18 | ±0,000 | ±0,00% | 0,000 | 0,000 | 98,500 | 98,500 |
